These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11246666)

  • 1. Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins in rheumatic and vascular diseases.
    Dominguez M; Cacoub P; Garcia de la Torre I; Piette TJ; Salazar-Paramo M; Godeau P; Angleés-Cano E
    J Rheumatol; 2001 Feb; 28(2):302-8. PubMed ID: 11246666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosis.
    Fritzler MJ; Hart DA; Wilson D; García-De La Torre I; Salazar-Páramo M; Vázquez-Del Mercado M; Senécal JL; Loyau S; Anglés-Cano E
    J Rheumatol; 1995 Sep; 22(9):1688-93. PubMed ID: 8523346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to fibrin-bound tissue-type plasminogen activator in systemic lupus erythematosus are associated with Raynaud's phenomenon and thrombosis.
    Salazar-Paramo M; Garcia de la Torre I; Fritzler MJ; Loyau S; Anglés-Cano E
    Lupus; 1996 Aug; 5(4):275-8. PubMed ID: 8869898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
    Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
    Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against aggrecan in systemic rheumatic diseases.
    Vynios DH; Tsagaraki I; Grigoreas GH; Samiotaki M; Panayotou G; Kyriakopoulou D; Georgiou P; Korbakis D; Panayotou A; Nanouri K; Assouti M; Andonopoulos AP
    Biochimie; 2006 Jul; 88(7):767-73. PubMed ID: 16488067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells.
    Patterson AM; Ford I; Graham A; Booth NA; Greaves M
    Br J Haematol; 2006 May; 133(3):323-30. PubMed ID: 16643435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous fibrin-coated small-caliber vascular prostheses improve antithrombogenicity by reducing immunologic response.
    Hasegawa T; Okada K; Takano Y; Hiraishi Y; Okita Y
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1268-76, 1276.e1. PubMed ID: 17467440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome.
    Cugno M; Dominguez M; Cabibbe M; Bisiani G; Galli M; Angles-Cano E; Agostoni A
    Br J Haematol; 2000 Mar; 108(4):871-5. PubMed ID: 10792298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies to distinct epitopes of the tissue-type plasminogen activator (t-PA) in patients with systemic lupus erythematosus.
    Ruiz-Arguelles A; Angles-Cano E; Perez-Romano B; Ruiz-Arguelles GJ; Deleze M; Alarcon-Segovia D; Gaussem P
    Am J Hematol; 1995 Jun; 49(2):109-14. PubMed ID: 7539580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
    Gargan PE; Ploplis VA; Scheu JD
    Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
    Diamond MP; Kruger M; Saed GM
    Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen.
    Clavel C; Nogueira L; Laurent L; Iobagiu C; Vincent C; Sebbag M; Serre G
    Arthritis Rheum; 2008 Mar; 58(3):678-88. PubMed ID: 18311806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
    Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
    Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome.
    Blank M; Krause I; Magrini L; Spina G; Kalil J; Jacobsen S; Thiesen HJ; Cunningham MW; Guilherme L; Shoenfeld Y
    Rheumatology (Oxford); 2006 Jul; 45(7):833-41. PubMed ID: 16705050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High diagnostic value of anticalpastatin autoantibodies in rheumatoid arthritis detected by ELISA using human erythrocyte calpastatin as antigen.
    Iwaki-Egawa S; Matsuno H; Yudoh K; Nakazawa F; Miyazaki K; Ochiai A; Hirohata S; Shimizu M; Watanabe Y
    J Rheumatol; 2004 Jan; 31(1):17-22. PubMed ID: 14705213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease.
    Lee KH; Chung HS; Kim HS; Oh SH; Ha MK; Baik JH; Lee S; Bang D
    Arthritis Rheum; 2003 Jul; 48(7):2025-35. PubMed ID: 12847697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.